Nimulide, gel 1% 30 g

Nimulide is a non-narcotic anti-inflammatory drug (NSAID) of sulfonanilide class, a selective COX-2 inhibitor. It has anti-inflammatory, analgesic, antipyretic effects.

Nimesulide belongs to NSAIDs, the mechanism of action of which is connected with selective inhibition of COX-2 and influence on several other factors – inhibition of platelet-activating factor, tumor necrosis factor-alpha, inhibition of proteinases and histamine.

With selective inhibition of COX-2 it decreases biosynthesis of PG in inflammation focus, has less pronounced inhibitory effect on COX-1 (causes side effects connected with inhibition of PG synthesis in healthy tissues less frequently).

.

Indications

Gout, Back pain, Arthritis, Osteochondrosis, Radiculitis, Osteoarthritis, Sciatica, Neck pain, Tendon inflammation, Joint pain (arthralgia), Pain after injuries and operations, Rheumatoid arthritis, Arthritis, Lumbago, Myalgia (muscle pain), Myositis, Sprains and strains.p> The drug is intended for symptomatic therapy, reducing pain and inflammation at the time of use, does not affect the progression of the disease.

• rheumatoid arthritis;
• joint syndrome with gout exacerbation;
• psoriatic arthritis;
• ankylosing spondylitis;

osteochondrosis with radicular syndrome;

• osteoarthritis;
• myalgia of rheumatic and non-rheumatic genesis;
• inflammation of ligaments, tendons, bursitis, including post-traumatic inflammation.
• Post-traumatic inflammation of soft tissue
• Pain syndrome of different genesis (including. in postoperative period, trauma, algodysmenorrhea, toothache, headache, arthralgia, lumboiscialgia);
• fever syndrome in infectious and inflammatory diseases.

.

Active ingredient

Nimesulide

Composition

Active ingredient:

Nimesulide 10 mg;

Associates:

Hyprolose; carbomer;

95% ethyl alcohol (purified);

purified water;

triacetin;

br>

dimethylacetamide;

phosphoric acid;

MSC-03 flavoring;

Flavoring 0106-G

How to take, the dosage

For external use. The areas of skin treated with the gel must not be covered with occlusive dressings.

The gel should also not be massively rubbed into the skin.

About 3 cm of gel should be applied to the affected area 3 to 4 times a day. The dosage, however, may vary according to the size of the area to be treated and the patient’s reaction. We evaluate the treatment after 4 weeks.

Interaction

The effect of drugs that reduce blood clotting is increased when they are used simultaneously with nimesulide.

Nimesulide may reduce the effect of furosemide. Reduces the therapeutic effect of antihypertensive drugs. Nimesulide increases the onset of side effects when concomitant administration of methotrexate.

Plasma lithium levels are increased when concomitant administration of lithium and nimesulide.

Nimesulide may increase the nephrotoxic effect of cyclosporine on the kidneys.

The use with glucocorticosteroids, serotonin reuptake inhibitors increases the risk of GI bleeding.

.

Special Instructions

Nimulide should be used with caution in patients who are prone to bleeding, patients with upper gastrointestinal disorders or patients receiving anticoagulants.

Because Nimulide is partially excreted by the kidneys, its dosage should be reduced for patients with impaired renal function, depending on creatinine clearance values.
Given reports of visual disturbances in patients taking other NSAIDs, treatment should be stopped immediately if any visual disturbance appears, and the patient should be examined by an eye doctor.
P

The drug may cause fluid retention in the tissues, so patients with high blood pressure and with cardiac abnormalities should use Nimulide with extreme caution.

To reduce the risk of gastrointestinal adverse events, the lowest effective dose should be used for the shortest possible course.
Influence on driving and operating machinery

Patients who have pronounced side effects: dizziness, somnolence, blurred vision should be careful when driving motor transport and engaging in other potentially dangerous activities requiring increased concentration and quick psychomotor reactions.

.

Contraindications

• high sensitivity to nimesulide and other Nimulide components;
• acetylsalicylic acid or other NSAIDs;
• gastric and duodenal ulcers in the acute phase;
• explicit hepatic and renal dysfunction.

.

Side effects

Systemic reactions: Heartburn, nausea, vomiting, diarrhea, gastralgia, gastrointestinal mucosal ulceration, headache, dizziness, fluid retention, drowsiness, itching, urticaria, bronchospasm, allergic reactions (skin rash, anaphylactic shock), thrombocytopenia, leukopenia, anemia, agranulocytosis, increased liver transaminase activity, prolonged bleeding time, hematuria.

Local reactions (gel): skin irritation, skin rash, peeling, skin itching, transient change in skin color (not requiring withdrawal of the drug).

.

Overdose

Symptoms: apathy, drowsiness, nausea, vomiting. Gastrointestinal bleeding, arterial hypertension, acute renal failure, respiratory depression may occur.

Treatment: symptomatic treatment of the patient is required, there is no specific antidote. If overdose occurred within the last 4 hours it is necessary to induce vomiting, provide intake of activated charcoal (60-100 g per adult), osmotic laxatives. Forced diuresis and hemodialysis are ineffective due to high protein binding of the drug.

.

Pregnancy use

It is contraindicated during pregnancy and lactation.

.

Similarities

Naiz, Nimesil, Nimesulide, Nemulex, Nimesulide-TEVA, Nimulide, Nimesan tablets 100 mg 20 pcs, Naisulide, Mialais